Harrow enters 340B Prime Vendor Program contract with Apexus

Harrow announced that it has entered into an agreement with Apexus to make Iheezo 3% and other Harrow products available through its 340B Prime Vendor Program. Iheezo, indicated for ocular anesthesia, is a low-viscosity topical ocular anesthetic gel with reliable efficacy, a proven safety profile, and simple administration. Other Harrow products available through the program include Vigamox, a topical eye drop for bacterial conjunctivitis, and Ilevro, an ocular nonsteroidal anti-inflammatory topical eye drop for pain and inflammation.